<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>KFF Health News</provider_name><provider_url>https://kffhealthnews.org</provider_url><author_name>brilabuskes</author_name><author_url>https://kffhealthnews.org/news/author/brilabuskes/</author_url><title>HHS Nominee Sticks To Conservative Talking Points On Drug Prices: 'There's No Silver Bullet Here' - KFF Health News</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="ajsqi2zLSk"&gt;&lt;a href="https://kffhealthnews.org/morning-breakout/hhs-nominee-sticks-to-conservative-talking-points-on-drug-prices-theres-no-silver-bullet-here/"&gt;HHS Nominee Sticks To Conservative Talking Points On Drug Prices: &#x2018;There&#x2019;s No Silver Bullet Here&#x2019;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/hhs-nominee-sticks-to-conservative-talking-points-on-drug-prices-theres-no-silver-bullet-here/embed/#?secret=ajsqi2zLSk" width="600" height="338" title="&#x201C;HHS Nominee Sticks To Conservative Talking Points On Drug Prices: &#x2018;There&#x2019;s No Silver Bullet Here&#x2019;&#x201D; &#x2014; KFF Health News" data-secret="ajsqi2zLSk" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>At his second Senate hearing, Alex Azar was grilled by Democrats on the Finance Committee questioning his commitment to bringing down high drug costs because of his ties to the pharmaceutical industry. Azar shied away from endorsing the idea of the government to negotiating prices, a concept touted by President Donald Trump.</description></oembed>
